All sites C00-96,D32-33,D42-43,D45-47,D76 630 88.9 2.7 2.3 1.5 4.6
Mouth, pharynx C00-14 12 95.2 1.6 - - 3.2
  Lip C00 1 100.0 - - - -
  Tongue C02 3 100.0 - - - -
  Mouth, other C03-06 4 95.5 - - - 4.5
  Salivary glands C07-08 2 83.3 8.3 - - 8.3
  Pharynx C01,C09-14 2 100.0 - - - -
Digestive organs C15-26 127 82.2 0.9 5.2 2.5 9.1
  Oesophagus C15 4 89.5 - - - 10.5
  Stomach C16 12 96.7 - - - 3.3
  Small intestine C17 3 87.5 - 12.5 - -
  Colon C18 46 93.5 - 0.4 1.3 4.8
  Rectum, rectosigmoid C19-20 18 94.4 - - - 5.6
  Anus C21 1 100.0 - - - -
  Liver C22 8 61.9 - 14.3 - 23.8
  Gallbladder, bile ducts C23-24 4 77.3 - 9.1 - 13.6
  Pancreas C25 27 59.6 4.4 14.7 5.9 15.4
  Other digestive organs C26 3 26.7 - 13.3 33.3 26.7
Respiratory organs C30-39 27 74.6 7.5 3.0 4.5 10.4
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 0 100.0 - - - -
  Lung, trachea C33-34 25 74.0 7.9 2.4 4.7 11.0
  Mediastinum, pleura C38 - - - - - -
Bone C40-41 1 80.0 - - - 20.0
Melanoma of the skin C43 25 100.0 - - - -
Skin, non-melanoma C44 42 100.0 - - - -
Mesothelioma C45 1 100.0 - - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 6 96.4 - 3.6 - -
Breast C50 190 99.2 - 0.2 0.2 0.4
Female genital organs C51-58 74 93.5 1.4 2.7 0.8 1.6
  Cervix uteri C53 6 96.7 - - 3.3 -
  Corpus uteri C54 35 99.4 - 0.6 - -
  Uterus, other C55,C58 1 33.3 - 33.3 - 33.3
  Ovary C56 23 88.0 2.6 6.0 - 3.4
  Other female genital C51-52,C57 8 85.4 4.9 2.4 4.9 2.4
Urinary organs C64-68 25 85.8 - 4.7 1.6 7.9
  Kidney C64 16 78.8 - 7.5 2.5 11.3
  Bladder and urinary tract2 C65-68 9 97.9 - - - 2.1
Eye C69 1 60.0 - - 20.0 20.0
Brain, central nervous system C70-72,D32-33,D42-43 21 82.7 - 3.8 1.9 11.5
Thyroid gland C73 8 95.2 2.4 - 2.4 -
Other endocrine glands C74-75 0 50.0 - 50.0 - -
Illdefined or unknown C76,C80 13 49.2 12.3 12.3 3.1 23.1
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 56 67.5 19.6 1.1 3.9 7.9
  Hodgkin lymphoma C81 3 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 27 97.0 - - 0.7 2.2
  Malignant immunoproliferative diseases C88 - - - - - -
  Myeloma and other plasma cell tumors C90 9 37.0 37.0 6.5 8.7 10.9
  Leukaemia C91-95 9 40.9 31.8 - 4.5 22.7
  Myelodysplastic syndromes D46 1 16.7 16.7 - 16.7 50.0
  Myeloproliferaitive neoplasms D45,D47 7 20.6 67.6 - 8.8 2.9
Not included above
  Carcinoma in situ of the breast D05 12 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 16 100.0 - - - -
  Borderline tumour of the ovary D39 11 96.5 - - - 3.5
  Basal cell carcinoma of the skin 215 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.